Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Braveheart says investee company Paraytec plans to raise £4mln in equity fundraising

Paraytec said the funds will go towards further development, regulatory approval and commercialisation of its innovative urine test for the detection and monitoring of bladder cancer
Braveheart currently has a 42% aggregate holding in Paraytec's current share capital

Braveheart Investment Group PLC (LON:BRH) noted that investee company Paraytec Limited has engaged an adviser to raise £4mln in equity fundraising.

Paraytec said the funds will be used for further development, regulatory approval and commercialisation of its innovative urine test for the detection and monitoring of bladder cancer.

READ: Braveheart’s profits nearly double as portfolio value jumps

The AIM-listed fund management and strategic investor group currently has a 42% aggregate holding in Paraytec's current share capital. 

Braveheart said that, given the level of its existing shareholding in Paraytec, the group does not intend to participate in the equity fundraising, though it is fully supportive of the strategic rationale for it to take place.

Trevor Brown, Braveheart’s CEO said: 'Paraytec's bladder cancer test shows excellent results in the laboratory and, once clinical trials are successfully completed, it will address a significant clinical need for a simple and non-invasive test for detecting and monitoring bladder cancer.

“The funds will be used to complete the development programme and conduct the clinical study required to obtain the necessary regulatory approvals and commercialise the test.”

View full BRH profile View Profile

Braveheart Investment Group Timeline

Related Articles

June 26 2018
The mineral resources investor thinks the macroeconomic environment is favourable to the mining sector. It has four investments that over the next 18 months or so could see it repeat the success it had with its investment in the Prognoz silver project in Russia.
July 12 2018
There’s a good chance one (or all) might end up being the future for Braveheart.

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use